Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TMEM139 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CASP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GSTK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CLCN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TAS2R40 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM131B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TAS2R39 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OR6W1P - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
KEL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C7orf34 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRPV5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on